Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 36

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 36
---
, (i) an amount in cash from the Company equal to the Cash Amount less the applicable exercise price in respect of such Option, and (ii) one CVR, and (B) in respect           
 of each RSU, (i) an amount in cash from the Company equal to the Cash Amount, and (ii) one CVR, and in each case, such Option or RSU will immediately be cancelled. In the event the exercise price of any Option is greater than or equal to        
 the Cash Amount, neither the Company nor the Purchaser shall be obligated to pay the holder of such Option the Consideration or any other amount in respect of such Option, and the Option shall be immediately cancelled without any payment.       |

| Q: | How does the Board recommend that I vote? |

| A: | Based in part on the unanimous recommendation of the Transaction Committee and the advice of its independent 
 legal and financial advisors, the Board recommends unanimously that our Shareholders vote:                   |

| • |     | “FOR” the Arrangement Resolution adopting the Agreement, the Plan of Arrangement and the 
 transactions contemplated thereby.                                                       |

| • |     | “FOR” the Compensation Resolution |

| • |     | “FOR” the Liquidation Resolution. |

| • |     | “FOR” the Liquidator Resolution. |

You should read “ Recommendation of the Transaction Committee; Reasons for the Arrangement; and Recommendation of the Board” for a discussion of the factors that the Transaction Committee and the Board considered in deciding to recommend and/or approve, as applicable, the Agreement. See also “ Interests of the Company’s Directors and Executive Officers in the Arrangement.”

| Q: | What vote is required to approve the Arrangement Resolution? |

| A: | Approval of the Arrangement Resolution requires the affirmative vote of not less than (i) 662⁄3% of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special Meeting, and (ii) a simple majority of the votes 
 attached to Common Shares held by Shareholders present in person (virtually) or represented by proxy at the Special Meeting excluding for this purpose votes attached to Common Shares held by persons described in items (a) through (d) of section     
 8.1(2) of MI 61-101. See “Interests of the Company’s Directors and Executive Officers in the Arrangement — Canadian Securities Law Matters ” for more information. As                                                                                    
 of November